Literature DB >> 3355891

The effect of erythroid hyperplasia on iron balance.

P Pootrakul1, K Kitcharoen, P Yansukon, P Wasi, S Fucharoen, P Charoenlarp, G Brittenham, M J Pippard, C A Finch.   

Abstract

Measurements of erythropoiesis and iron balance were made in eight normal and 32 anemic subjects. The latter consisted of 12 individuals with ineffective erythropoiesis (beta-thalassemia/hemoglobin E), 13 subjects with ineffective erythropoiesis and hemolytic anemia (hemoglobin H), and seven subjects with hemolytic anemia (hereditary spherocytosis). A consistent relationship within each group existed between the degree of erythropoiesis and radioiron absorption. Although the effect of erythropoiesis on iron absorption was of similar magnitude in the two thalassemia groups, the effect in hereditary spherocytosis was much less. There was agreement between absorption and ferritin or magnetic susceptibility (SQUID) measurements of iron stores in thalassemia, but in hereditary spherocytosis a discrepancy existed between absorption and ferritin. It is concluded that, although increased erythropoiesis is associated with increased iron absorption, some additional factor associated with red cell breakdown is more directly responsible for the positive iron balance in thalassemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3355891

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  28 in total

1.  Molecular basis of congenital dyserythropoietic anemia type II and genotype-phenotype relationship.

Authors:  Mario Cazzola; Rosangela Invernizzi
Journal:  Haematologica       Date:  2010-05       Impact factor: 9.941

2.  Iron overload correlates with serum liver fibrotic markers and liver dysfunction: Potential new methods to predict iron overload-related liver fibrosis in thalassemia patients.

Authors:  Man Wang; Rongrong Liu; Yuzhen Liang; Gaohui Yang; Yumei Huang; Chunlan Yu; Kaiqi Sun; Yongrong Lai; Yang Xia
Journal:  United European Gastroenterol J       Date:  2016-06-23       Impact factor: 4.623

3.  Beta-thalassaemia/haemoglobin E tissue ferritins. II: A comparison of heart and pancreas ferritins with those of liver and spleen.

Authors:  K C Tran; J Webb; D J Macey; P Pootrakul
Journal:  Biol Met       Date:  1990

4.  Beta-thalassaemia/haemoglobin E tissue ferritins. I: Purification and partial characterization of liver and spleen ferritins.

Authors:  K C Tran; J Webb; D J Macey; P Pootrakul; P Yansukon
Journal:  Biol Met       Date:  1990

5.  Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice.

Authors:  Huihui Li; Tenzin Choesang; Weili Bao; Huiyong Chen; Maria Feola; Daniel Garcia-Santos; Jie Li; Shuming Sun; Antonia Follenzi; Petra Pham; Jing Liu; Jinghua Zhang; Prem Ponka; Xiuli An; Narla Mohandas; Robert E Fleming; Stefano Rivella; Guiyuan Li; Yelena Z Ginzburg
Journal:  Blood       Date:  2017-02-01       Impact factor: 22.113

6.  Normal iron metabolism and the pathophysiology of iron overload disorders.

Authors:  Chiang W Siah; John Ombiga; Leon A Adams; Debbie Trinder; John K Olynyk
Journal:  Clin Biochem Rev       Date:  2006-02

Review 7.  Regulation of iron absorption in hemoglobinopathies.

Authors:  Gideon Rechavi; Stefano Rivella
Journal:  Curr Mol Med       Date:  2008-11       Impact factor: 2.222

8.  Organ-specific crystalline structures of ferritin cores in beta-thalassemia/hemoglobin E.

Authors:  T G St Pierre; K C Tran; J Webb; D J Macey; B R Heywood; N H Sparks; V J Wade; S Mann; P Pootrakul
Journal:  Biol Met       Date:  1991

9.  Transferrin therapy ameliorates disease in beta-thalassemic mice.

Authors:  Huihui Li; Anne C Rybicki; Sandra M Suzuka; Leni von Bonsdorff; William Breuer; Charles B Hall; Z Ioav Cabantchik; Eric E Bouhassira; Mary E Fabry; Yelena Z Ginzburg
Journal:  Nat Med       Date:  2010-01-24       Impact factor: 53.440

10.  Update on the use of deferasirox in the management of iron overload.

Authors:  Ali Taher; Maria Domenica Cappellini
Journal:  Ther Clin Risk Manag       Date:  2009-11-02       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.